Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Biomarker Research|April 2, 2022
Donor T cells for CAR T cell therapyTiffany C Y Tang, Ning Xu, Robert Nordon, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Cell-based methods for the identification of MYC-inhibitory small moleculesCatherine A Burkhart, Michelle Haber, Murray D Norris, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
Cell-Based Methods for the Identification of Myc-Inhibitory Small MoleculesCatherine A Burkhart, Michelle Haber, Murray D Norris, et al.
Translational Pediatrics|February 3, 2016
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaHamid Bassiri, Adriana Benavides, Michelle Haber, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Pharmacogenetics and Genomics|February 15, 2011
ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcriptMarina Pajic, Jayne Murray, Glenn M Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemiaStephen J Laughton, Lesley J Ashton, Edward Kwan, et al.
Current Protocols|November 26, 2021
A Primer for Assessing the Pathology in Mouse Models of NeuroblastomaAndrew J Gifford, Jayne Murray, Jamie I Fletcher, et al.
Immunotargets and Therapy|May 6, 2021
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell TherapyNing Xu, Benjamin Tse, Lu Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Prognostic significance of promoter DNA methylation in patients with childhood neuroblastomaDiana T Lau, Luke B Hesson, Murray D Norris, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Biomarker Research|April 2, 2022
Donor T cells for CAR T cell therapyTiffany C Y Tang, Ning Xu, Robert Nordon, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
Cell-based methods for the identification of MYC-inhibitory small moleculesCatherine A Burkhart, Michelle Haber, Murray D Norris, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
Cell-Based Methods for the Identification of Myc-Inhibitory Small MoleculesCatherine A Burkhart, Michelle Haber, Murray D Norris, et al.
Translational Pediatrics|February 3, 2016
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaHamid Bassiri, Adriana Benavides, Michelle Haber, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Pharmacogenetics and Genomics|February 15, 2011
ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcriptMarina Pajic, Jayne Murray, Glenn M Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemiaStephen J Laughton, Lesley J Ashton, Edward Kwan, et al.
Current Protocols|November 26, 2021
A Primer for Assessing the Pathology in Mouse Models of NeuroblastomaAndrew J Gifford, Jayne Murray, Jamie I Fletcher, et al.
Immunotargets and Therapy|May 6, 2021
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell TherapyNing Xu, Benjamin Tse, Lu Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Prognostic significance of promoter DNA methylation in patients with childhood neuroblastomaDiana T Lau, Luke B Hesson, Murray D Norris, et al.
Pageof 19